FibroBiologics (FBLG) said late Monday it has closed the second $5 million tranche of its standby equity purchase agreement with YA II PN, an investment fund managed by Yorkville Advisors Global.
The biotech company said it expects to use net proceeds from the financing tranche for general corporate purposes.
The equity purchase agreement lets FibroBiologics sell up to $25 million of its shares to Yorkville over two years, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.